搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
6 天
ESMO中国之声丨罗婷教授:HLX02、吡咯替尼与白蛋白紫杉醇联合方案新 ...
HLX02(中国商品名:汉曲优),是中国首个自主研发的曲妥珠单抗生物类似药,在中国、欧盟、美国等多个国家和区域均获批上市。随着吡咯替尼新辅助适应症在中国的获批,曲妥珠单抗联合吡咯替尼和化疗也成为了HER2阳性早期或局部晚期乳腺癌新辅助治疗的可选方案之 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Secret Service admits failure
Accepts CNN debate invite
FBI agents board vessel
$230 million crypto theft
Rallies in North Carolina
J&J unit files for bankruptcy
Beirut strike death toll
Released after guilty plea
Pandas leaving for China
Hand count approved in GA
House repeals emission rules
Drug price challenge revived
Stein's ballot bid rejected
FDA approves flu vaccine
Russia threatens retaliation
Feds subpoena Schaeffer
Bill to boost security OK'd
Boeing defense chief exits
Sesame Place suit verdict
1st rabies outbreak in seals
TN abortion law blocked
Disney to stop using Slack
In-person voting begins
144K+ Mavericks recalled
Hiker injured in bear attack
WI high court to decide
SC 1st execution in 13 years
ISR strike on Gaza school
Baby powder recalled
Top Hezbollah leader killed?
Sues pharmacy middlemen
反馈